FY2024 Earnings Estimate for Integer Holdings Co. (NYSE:ITGR) Issued By Zacks Research

Integer Holdings Co. (NYSE:ITGR - Free Report) - Analysts at Zacks Research lifted their FY2024 earnings per share (EPS) estimates for Integer in a research note issued to investors on Wednesday, May 8th. Zacks Research analyst D. Dey now expects that the medical equipment provider will earn $5.26 per share for the year, up from their prior forecast of $5.25. The consensus estimate for Integer's current full-year earnings is $5.27 per share. Zacks Research also issued estimates for Integer's Q1 2025 earnings at $1.30 EPS, Q2 2025 earnings at $1.47 EPS, Q3 2025 earnings at $1.61 EPS, Q4 2025 earnings at $1.71 EPS, FY2025 earnings at $6.09 EPS and Q1 2026 earnings at $1.66 EPS.

Several other analysts have also recently issued reports on the company. Benchmark reiterated a "buy" rating and set a $130.00 target price on shares of Integer in a research report on Friday. KeyCorp increased their price target on Integer from $123.00 to $139.00 and gave the company an "overweight" rating in a research note on Tuesday, April 9th. Bank of America raised Integer from a "neutral" rating to a "buy" rating and increased their price target for the company from $105.00 to $135.00 in a research note on Monday, April 15th. Finally, CL King assumed coverage on Integer in a research note on Thursday, March 14th. They set a "buy" rating and a $137.00 price target for the company. Three analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $120.50.

Integer Price Performance

Shares of NYSE:ITGR traded down $0.28 during trading on Friday, hitting $113.95. 206,477 shares of the company's stock were exchanged, compared to its average volume of 335,044. The company has a debt-to-equity ratio of 0.76, a current ratio of 3.32 and a quick ratio of 2.01. Integer has a 52-week low of $69.40 and a 52-week high of $123.99. The business's 50-day simple moving average is $114.74 and its 200 day simple moving average is $102.06. The company has a market cap of $3.82 billion, a price-to-earnings ratio of 39.30, a PEG ratio of 1.65 and a beta of 1.12.

Integer (NYSE:ITGR - Get Free Report) last released its earnings results on Thursday, April 25th. The medical equipment provider reported $1.14 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.12 by $0.02. Integer had a return on equity of 11.25% and a net margin of 6.01%. The firm had revenue of $414.80 million during the quarter, compared to analysts' expectations of $412.78 million. During the same quarter last year, the business posted $0.87 earnings per share. The firm's revenue was up 9.5% on a year-over-year basis.

Insider Activity

In related news, SVP Andrew Senn sold 5,000 shares of the firm's stock in a transaction that occurred on Tuesday, May 7th. The stock was sold at an average price of $113.14, for a total transaction of $565,700.00. Following the completion of the sale, the senior vice president now directly owns 4,658 shares of the company's stock, valued at approximately $527,006.12. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other Integer news, SVP Andrew Senn sold 5,000 shares of the firm's stock in a transaction on Tuesday, May 7th. The stock was sold at an average price of $113.14, for a total transaction of $565,700.00. Following the transaction, the senior vice president now directly owns 4,658 shares in the company, valued at approximately $527,006.12. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP John A. Harris sold 312 shares of the firm's stock in a transaction on Tuesday, May 7th. The stock was sold at an average price of $113.00, for a total value of $35,256.00. Following the transaction, the executive vice president now owns 1,157 shares in the company, valued at $130,741. The disclosure for this sale can be found here. Insiders sold 6,812 shares of company stock valued at $771,956 in the last ninety days. Insiders own 2.00% of the company's stock.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the company. Blue Trust Inc. increased its holdings in shares of Integer by 483.3% in the 4th quarter. Blue Trust Inc. now owns 455 shares of the medical equipment provider's stock valued at $45,000 after acquiring an additional 377 shares during the period. Principal Securities Inc. purchased a new position in shares of Integer in the 4th quarter valued at $67,000. Headlands Technologies LLC purchased a new position in shares of Integer in the 1st quarter valued at $106,000. Quadrant Capital Group LLC increased its holdings in shares of Integer by 10.2% in the 4th quarter. Quadrant Capital Group LLC now owns 1,427 shares of the medical equipment provider's stock valued at $141,000 after acquiring an additional 132 shares during the period. Finally, Strs Ohio increased its holdings in shares of Integer by 54.5% in the 4th quarter. Strs Ohio now owns 1,700 shares of the medical equipment provider's stock valued at $168,000 after acquiring an additional 600 shares during the period. 99.29% of the stock is currently owned by hedge funds and other institutional investors.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.